InnoPharmax Inc. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was TWD 136.881 million compared to TWD 84.891 million a year ago. Operating loss was TWD 30.324 million compared to TWD 74.948 million a year ago. Net loss was TWD 43.898 million compared to TWD 87.893 million a year ago. Basic loss per share was TWD 0.57 compared to TWD 1.24 a year ago.